Consainsights logo
Life Sciences

Neurodegenerative Disease Market

Indication Type, Drug Type.
License Type
What you get?
  • Online view only
  • Delivered in 24-72 hours
  • Only a single designated user can access the report
  • 5 hours of analyst support

Executive Summary

Neurodegenerative Disease Market from Consainsights analyses the Neurodegenerative Disease Market in the Technology & Media industry over the forecast period to 2026.

Neurodegenerative Disease research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Neurodegenerative Disease segmentation includes Drug Type, Indication Type and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Drug Type, the Neurodegenerative Disease Market analysis covers Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, N-methyl-D-aspartate Receptor antagonists, Other Drug Types.

Based on the Indication Type, the Neurodegenerative Disease Market analysis covers Alzheimer's Disease, Huntington Disease, Multiple Sclerosis, Other Indication Types, Parkinson's Disease.

Key companies operating in the market include UCB SA, Biogen Inc., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals Inc., Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical, F. Hoffmann-La Roche Ltd, Novartis AG, AbbVie Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Report Metric

Details

Market size available for years

2012-2027

Base year considered

2021

Forecast period

2022-2027

Forecast units

Value (USD Billion)

Segments covered

Drug Type, Indication Type

Geographies covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Companies Covered

UCB SA, Biogen Inc., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals Inc., Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical, F. Hoffmann-La Roche Ltd, Novartis AG, AbbVie Inc.


Table of Contents

  1. Executive Summary

  2. Neurodegenerative Disease Market Overview

    1. Neurodegenerative Disease Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Neurodegenerative Disease Market 360° Synopsis: Overview
  3. Neurodegenerative Disease Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Neurodegenerative Disease Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Neurodegenerative Disease Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Neurodegenerative Disease Market: Drug Type

    1. Introduction
    2. Cholinesterase Inhibitors: Market Trends, Size, and Forecast (2017-2026)
    3. Dopamine Agonists: Market Trends, Size, and Forecast (2017-2026)
    4. Immunomodulatory Drugs: Market Trends, Size, and Forecast (2017-2026)
    5. N-methyl-D-aspartate Receptor antagonists: Market Trends, Size, and Forecast (2017-2026)
    6. Other Drug Types: Market Trends, Size, and Forecast (2017-2026)
  6. Neurodegenerative Disease Market: Indication Type

    1. Introduction
    2. Alzheimer's Disease: Market Trends, Size, and Forecast (2017-2026)
    3. Huntington Disease: Market Trends, Size, and Forecast (2017-2026)
    4. Multiple Sclerosis: Market Trends, Size, and Forecast (2017-2026)
    5. Other Indication Types: Market Trends, Size, and Forecast (2017-2026)
    6. Parkinson's Disease: Market Trends, Size, and Forecast (2017-2026)
  7. Global Analysis

    1. Global Neurodegenerative Disease Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  8. Middle East & Africa Analysis

    1. Middle East & Africa Neurodegenerative Disease Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East Neurodegenerative Disease Market: Drug Type
        3. Middle East Neurodegenerative Disease Market: Indication Type
      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa Neurodegenerative Disease Market: Drug Type
        3. Africa Neurodegenerative Disease Market: Indication Type
      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa Neurodegenerative Disease Market: Drug Type
        3. Rest of Middle East & Africa Neurodegenerative Disease Market: Indication Type
    2. Middle East & Africa Neurodegenerative Disease Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Cholinesterase Inhibitors: Market Trends, Size, and Forecast (2017-2026)
      3. Dopamine Agonists: Market Trends, Size, and Forecast (2017-2026)
      4. Immunomodulatory Drugs: Market Trends, Size, and Forecast (2017-2026)
      5. N-methyl-D-aspartate Receptor antagonists: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drug Types: Market Trends, Size, and Forecast (2017-2026)
    3. Middle East & Africa Neurodegenerative Disease Market, By Indication Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Alzheimer's Disease: Market Trends, Size, and Forecast (2017-2026)
      3. Huntington Disease: Market Trends, Size, and Forecast (2017-2026)
      4. Multiple Sclerosis: Market Trends, Size, and Forecast (2017-2026)
      5. Other Indication Types: Market Trends, Size, and Forecast (2017-2026)
      6. Parkinson's Disease: Market Trends, Size, and Forecast (2017-2026)
  9. Europe Analysis

    1. Europe Neurodegenerative Disease Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany Neurodegenerative Disease Market: Drug Type
        3. Germany Neurodegenerative Disease Market: Indication Type
      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom Neurodegenerative Disease Market: Drug Type
        3. United Kingdom Neurodegenerative Disease Market: Indication Type
      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France Neurodegenerative Disease Market: Drug Type
        3. France Neurodegenerative Disease Market: Indication Type
      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain Neurodegenerative Disease Market: Drug Type
        3. Spain Neurodegenerative Disease Market: Indication Type
      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia Neurodegenerative Disease Market: Drug Type
        3. Russia Neurodegenerative Disease Market: Indication Type
      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy Neurodegenerative Disease Market: Drug Type
        3. Italy Neurodegenerative Disease Market: Indication Type
      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe Neurodegenerative Disease Market: Drug Type
        3. Rest of Europe Neurodegenerative Disease Market: Indication Type
    2. Europe Neurodegenerative Disease Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Cholinesterase Inhibitors: Market Trends, Size, and Forecast (2017-2026)
      3. Dopamine Agonists: Market Trends, Size, and Forecast (2017-2026)
      4. Immunomodulatory Drugs: Market Trends, Size, and Forecast (2017-2026)
      5. N-methyl-D-aspartate Receptor antagonists: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drug Types: Market Trends, Size, and Forecast (2017-2026)
    3. Europe Neurodegenerative Disease Market, By Indication Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Alzheimer's Disease: Market Trends, Size, and Forecast (2017-2026)
      3. Huntington Disease: Market Trends, Size, and Forecast (2017-2026)
      4. Multiple Sclerosis: Market Trends, Size, and Forecast (2017-2026)
      5. Other Indication Types: Market Trends, Size, and Forecast (2017-2026)
      6. Parkinson's Disease: Market Trends, Size, and Forecast (2017-2026)
  10. Latin America Analysis

    1. Latin America Neurodegenerative Disease Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil Neurodegenerative Disease Market: Drug Type
        3. Brazil Neurodegenerative Disease Market: Indication Type
      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina Neurodegenerative Disease Market: Drug Type
        3. Argentina Neurodegenerative Disease Market: Indication Type
      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico Neurodegenerative Disease Market: Drug Type
        3. Mexico Neurodegenerative Disease Market: Indication Type
      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia Neurodegenerative Disease Market: Drug Type
        3. Colombia Neurodegenerative Disease Market: Indication Type
      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America Neurodegenerative Disease Market: Drug Type
        3. Rest of Latin America Neurodegenerative Disease Market: Indication Type
    2. Latin America Neurodegenerative Disease Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Cholinesterase Inhibitors: Market Trends, Size, and Forecast (2017-2026)
      3. Dopamine Agonists: Market Trends, Size, and Forecast (2017-2026)
      4. Immunomodulatory Drugs: Market Trends, Size, and Forecast (2017-2026)
      5. N-methyl-D-aspartate Receptor antagonists: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drug Types: Market Trends, Size, and Forecast (2017-2026)
    3. Latin America Neurodegenerative Disease Market, By Indication Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Alzheimer's Disease: Market Trends, Size, and Forecast (2017-2026)
      3. Huntington Disease: Market Trends, Size, and Forecast (2017-2026)
      4. Multiple Sclerosis: Market Trends, Size, and Forecast (2017-2026)
      5. Other Indication Types: Market Trends, Size, and Forecast (2017-2026)
      6. Parkinson's Disease: Market Trends, Size, and Forecast (2017-2026)
  11. North America Analysis

    1. North America Neurodegenerative Disease Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States Neurodegenerative Disease Market: Drug Type
        3. United States Neurodegenerative Disease Market: Indication Type
      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada Neurodegenerative Disease Market: Drug Type
        3. Canada Neurodegenerative Disease Market: Indication Type
    2. North America Neurodegenerative Disease Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Cholinesterase Inhibitors: Market Trends, Size, and Forecast (2017-2026)
      3. Dopamine Agonists: Market Trends, Size, and Forecast (2017-2026)
      4. Immunomodulatory Drugs: Market Trends, Size, and Forecast (2017-2026)
      5. N-methyl-D-aspartate Receptor antagonists: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drug Types: Market Trends, Size, and Forecast (2017-2026)
    3. North America Neurodegenerative Disease Market, By Indication Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Alzheimer's Disease: Market Trends, Size, and Forecast (2017-2026)
      3. Huntington Disease: Market Trends, Size, and Forecast (2017-2026)
      4. Multiple Sclerosis: Market Trends, Size, and Forecast (2017-2026)
      5. Other Indication Types: Market Trends, Size, and Forecast (2017-2026)
      6. Parkinson's Disease: Market Trends, Size, and Forecast (2017-2026)
  12. Asia-Pacific Analysis

    1. Asia-Pacific Neurodegenerative Disease Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China Neurodegenerative Disease Market: Drug Type
        3. China Neurodegenerative Disease Market: Indication Type
      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan Neurodegenerative Disease Market: Drug Type
        3. Japan Neurodegenerative Disease Market: Indication Type
      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India Neurodegenerative Disease Market: Drug Type
        3. India Neurodegenerative Disease Market: Indication Type
      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia Neurodegenerative Disease Market: Drug Type
        3. Southeast Asia Neurodegenerative Disease Market: Indication Type
      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand Neurodegenerative Disease Market: Drug Type
        3. Australia & New Zealand Neurodegenerative Disease Market: Indication Type
      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific Neurodegenerative Disease Market: Drug Type
        3. Rest of Asia-Pacific Neurodegenerative Disease Market: Indication Type
    2. Asia-Pacific Neurodegenerative Disease Market, By Drug Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Cholinesterase Inhibitors: Market Trends, Size, and Forecast (2017-2026)
      3. Dopamine Agonists: Market Trends, Size, and Forecast (2017-2026)
      4. Immunomodulatory Drugs: Market Trends, Size, and Forecast (2017-2026)
      5. N-methyl-D-aspartate Receptor antagonists: Market Trends, Size, and Forecast (2017-2026)
      6. Other Drug Types: Market Trends, Size, and Forecast (2017-2026)
    3. Asia-Pacific Neurodegenerative Disease Market, By Indication Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Alzheimer's Disease: Market Trends, Size, and Forecast (2017-2026)
      3. Huntington Disease: Market Trends, Size, and Forecast (2017-2026)
      4. Multiple Sclerosis: Market Trends, Size, and Forecast (2017-2026)
      5. Other Indication Types: Market Trends, Size, and Forecast (2017-2026)
      6. Parkinson's Disease: Market Trends, Size, and Forecast (2017-2026)
  13. Neurodegenerative Disease Market: Company Analysis

    1. Introduction
    2. UCB SA

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. Biogen Inc.

    4. Boehringer Ingelheim International GmbH

    5. Amneal Pharmaceuticals Inc.

    6. Merck & Co. Inc.

    7. Pfizer Inc.

    8. Teva Pharmaceutical

    9. F. Hoffmann-La Roche Ltd

    10. Novartis AG

    11. AbbVie Inc.

  14. Neurodegenerative Disease Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  15. Neurodegenerative Disease Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  16. Industry & Analysts Insights for Success

  17. Research Methodology

  18. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures & Tables

List of Figures

Figure: Global Neurodegenerative Disease Market: Structure

Figure: Global Neurodegenerative Disease Market: Value Chain Analysis

Figure: Global Neurodegenerative Disease Market: Porter's Five Forces Model

Figure: Global Neurodegenerative Disease Market: Market Dynamics

Figure: Global Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: North America Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: Europe Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: Asia-Pacific Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: Latin America Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: Middle East & Africa Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: Global Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: North America Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: Europe Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: Asia-Pacific Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: Latin America Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

Figure: Middle East & Africa Neurodegenerative Disease Market, By Neurodegenerative Disease, 2022-2027 (USD Million)

List of Tables

Table: Global Neurodegenerative Disease Market, By Drug Type, 2017-2026 (USD Million)

Table: North America Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: United States Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Canada Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Europe Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Germany Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: United Kingdom Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: France Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Spain Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Russia Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Italy Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Rest of Europe Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Asia-Pacific Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: China Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Japan Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: India Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Southeast Asia Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Australia & New Zealand Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Latin America Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Brazil Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Argentina Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Mexico Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Colombia Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Rest of Latin America Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Middle East & Africa Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Middle East Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Africa Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Neurodegenerative Disease Market, By Drug Type, 2022-2027 (USD Million)

Table: Global Neurodegenerative Disease Market, By Indication Type, 2017-2026 (USD Million)

Table: North America Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: United States Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Canada Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Europe Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Germany Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: United Kingdom Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: France Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Spain Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Russia Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Italy Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Rest of Europe Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Asia-Pacific Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: China Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Japan Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: India Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Southeast Asia Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Australia & New Zealand Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Latin America Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Brazil Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Argentina Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Mexico Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Colombia Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Rest of Latin America Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Middle East & Africa Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Middle East Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Africa Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Neurodegenerative Disease Market, By Indication Type, 2022-2027 (USD Million)